Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

nanomedicine Press Releases

  + XML/RSS  



By Nemucore Medical Innovations, Inc.
Worcester Polytechnic Institute grants Provost Award to Joseph Cacaccio and Eileen Wrabel for their major qualifying project work at Nemucore Medical Innovations.

By NanoAxis
Buffalo, NY and Thunder Bay, ON NanoAxis LLC has announced that it has become a shareholder in Canadian based company, NanoApps Medical Inc., to assist in accelerating nanomedical product development and commercialization. NanoApps Medical Inc.

By Biotech Support Group
Research experiment protocol on anti-angiogenic molecule docetaxel prodrug in perfluorocarbon (PFC) nanoparticles cites Cleanascite™ for lipid removal from plasma-enzyme-nanoparticle mixture.

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI) is a privately-held biopharmaceutical company dedicated to the development and commercialization of targeted nanomedicines for the treatment of patients afflicted with multidrug resistant cancers.

By Cambridge Healthtech Institute
Driving Innovation Through New Targets, Effective Tools, Next-Gen and Alternate Delivery Technologies

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI), a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the...

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI), a nanomedicine company dedicated to the development and commercialization of life-saving nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the appointment of..

By Nanoprobes, Inc.
Nanoprobes’ gold nanoparticles are being delivered to cancers for better diagnosis and treatment, using a peptide that targets the low pH environment of tumors.

All Press Releases

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI), a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the...

By Nemucore Medical Innovations, Inc.
Worcester Polytechnic Institute grants Provost Award to Joseph Cacaccio and Eileen Wrabel for their major qualifying project work at Nemucore Medical Innovations.

By NanoAxis
Buffalo, NY and Thunder Bay, ON NanoAxis LLC has announced that it has become a shareholder in Canadian based company, NanoApps Medical Inc., to assist in accelerating nanomedical product development and commercialization. NanoApps Medical Inc.

By Biotech Support Group
Research experiment protocol on anti-angiogenic molecule docetaxel prodrug in perfluorocarbon (PFC) nanoparticles cites Cleanascite™ for lipid removal from plasma-enzyme-nanoparticle mixture.

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI) is a privately-held biopharmaceutical company dedicated to the development and commercialization of targeted nanomedicines for the treatment of patients afflicted with multidrug resistant cancers.

By Cambridge Healthtech Institute
Driving Innovation Through New Targets, Effective Tools, Next-Gen and Alternate Delivery Technologies

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI), a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the...

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI), a nanomedicine company dedicated to the development and commercialization of life-saving nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the appointment of..

By Nanoprobes, Inc.
Nanoprobes’ gold nanoparticles are being delivered to cancers for better diagnosis and treatment, using a peptide that targets the low pH environment of tumors.

By Nanoprobes, Inc.
Researchers are curing cancer in 80%+ of mice with magnetic nanoparticles, after a single, three-minute treatment.

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI) announces it has received a Phase I U43 Small Business Innovation research grant from the National Cancer Institute.

By CRC Press
Graphene, Carbon Nanotubes, and Nanostructures: Techniques and Applications offers a comprehensive review of groundbreaking research in nanofabrication technology and explores myriad applications that this technology has enabled.

By Nemucore Medical Innovations, Inc.
NMI's Co-Founder Dr. Torchilin was named the recipient of the Journal of Drug Targeting’s Lifetime Achievement Award for 2012 for his work in multifunctional pharmaceutical nanocarriers.

By Ed Northon
After almost 9 months, the founding organization of the consortium Nanobot Research Group decided to increase the expected level of mutual cooperation.

By Ed Northon
Emirates Anticancer Pharmaceuticals announced the continuation of research and development activities on a new group of selective channel destructors of cell membranes for the years 2012 - 2014.

By SMi Group
How to select the most apporpriate formulation tool for poorly soluble drugs

By NanoTecNexus
NanoTecNexus announces a new series of business and scientific webinars intended for industry, investment, research, and academic communities. Topics include strategies in funding, regulatory safety, R&D, and commercialization of applications.

By Adriana Vela
--- NanoTecNexus and NanoTumor Center Education Projects Rank High ---

By OIC COMSTECH
The weeklong international workshop on Nanomedicine organized by Organisation of Islamic Conference Standing Committee on Scientific and Technological Cooperation (COMSTECH) has been launched at Islamabad, Pakistan.

By OIC COMSTECH
OIC COMSTECH is holding workshops on nano-medicine and bio-ethics education in Islamabad, Pakistan.

By Piribo
Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report which anticipates that there will be a boom between 2010 and 2015 in the nanobiotechnology market.




Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share